journal article·2021Open access

Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery

Marco Herrera, Jeonghwan Kim, Yulia Eygeris, Antony Jozic, Gaurav Sahay

Biomaterials Science· Volume 9· Issue 12

Abstract

Lipid-based nanoparticles (LNPs) for the delivery of mRNA have jumped to the forefront of non-viral gene delivery. Despite this exciting development, poor endosomal escape after LNP cell entry remains an unsolved, rate-limiting bottleneck. Here we report the use of a galectin 8-GFP (Gal8-GFP) cell reporter system to visualize the endosomal escape capabilities of LNP-encapsulated mRNA. LNPs substituted with phytosterols in place of cholesterol exhibited various levels of Gal8 recruitment in the Gal8-GFP reporter system. In live-cell imaging, LNPs containing β-sitosterol (LNP-Sito) showed a 10-fold increase in detectable endosomal perturbation events when compared to the standard cholesterol LNPs (LNP-Chol), suggesting the superior capability of LNP-Sito to escape from endosomal entrapment. Trafficking studies of these LNPs showed strong localization with late endosomes. This highly sensitive and robust Gal8-GFP reporter system can be a valuable tool to elucidate intricacies of LNP trafficking and ephemeral endosomal escape events, enabling advancements in gene delivery.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · RNA regulation and disease · Galectins and Cancer Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences

College of Pharmacy

Robertson Life Sciences Building

Oregon State University

Portland

Funding

National Heart, Lung, and Blood Institute · National Eye Institute · Cystic Fibrosis Foundation · National Institutes of Health · Oregon Health and Science University

References (48)

Show source-provided references
1. Sahin · Nat. Rev. Drug Discovery · 2014 · 13 · 75910.1038/nrd4278 ↗
2. Kaczmarek · Genome Med. · 2017 · 9 · 6010.1186/s13073-017-0450-0 ↗
3. Pack · Nat. Rev. Drug Discovery · 2005 · 4 · 58110.1038/nrd1775 ↗
4. Dowdy · Nat. Biotechnol. · 2017 · 35 · 22210.1038/nbt.3802 ↗
5. Yin · Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
6. Adams · N. Engl. J. Med. · 2018 · 379 · 1110.1056/NEJMoa1716153 ↗
7. Balwani · N. Engl. J. Med. · 2020 · 382 · 228910.1056/NEJMoa1913147 ↗
8. He · Acc. Chem. Res. · 2019 · 52 · 244510.1021/acs.accounts.9b00228 ↗
9. Walsh · N. Engl. J. Med. · 2020 · 383 · 243910.1056/NEJMoa2027906 ↗
10. Corbett · N. Engl. J. Med. · 2020 · 383 · 154410.1056/NEJMoa2024671 ↗
11. Patel · Adv. Drug Delivery Rev. · 2019 · 144 · 9010.1016/j.addr.2019.08.004 ↗
12. Sahay · Nat. Biotechnol. · 2013 · 31 · 65310.1038/nbt.2614 ↗
13. Kim · Theranostics · 2019 · 9 · 319110.7150/thno.33921 ↗
14. Gilleron · Nat. Biotechnol. · 2013 · 31 · 63810.1038/nbt.2612 ↗
15. Ballabio · EMBO Mol. Med. · 2016 · 8 · 7310.15252/emmm.201505966 ↗
16. Nakamura · J. Cell Sci. · 2017 · 130 · 120910.1242/jcs.196352 ↗
17. Wittrup · Nat. Biotechnol. · 2015 · 33 · 87010.1038/nbt.3298 ↗
18. Vermeulen · ACS Nano · 2018 · 12 · 233210.1021/acsnano.7b07583 ↗
19. Arthur · Methods Mol. Biol. · 2015 · 1207 · 110.1007/978-1-4939-1396-1_1 ↗
20. Rabinovich · Nat. Rev. Immunol. · 2009 · 9 · 33810.1038/nri2536 ↗
21. Stowell · Nat. Med. · 2010 · 16 · 29510.1038/nm.2103 ↗
22. Tsai · J. Immunol. · 2011 · 187 · 164310.4049/jimmunol.1100297 ↗
23. Thurston · Nature · 2012 · 482 · 41410.1038/nature10744 ↗
24. Johannes · J. Cell Sci. · 2018 · 131 · jcs20888410.1242/jcs.208884 ↗
25. Du Rietz · Nat. Commun. · 2020 · 11 · 180910.1038/s41467-020-15300-1 ↗
26. Kilchrist · ACS Nano · 2019 · 13 · 1136
27. Rui · Sci. Adv. · 2019 · 5 · eaay325510.1126/sciadv.aay3255 ↗
28. Patel · Nat. Commun. · 2020 · 11 · 98310.1038/s41467-020-14527-2 ↗
29. Kim · Cell. Mol. Bioeng. · 2020 · 1
30. Sato · Biochim. Biophys. Acta, Lipids Lipid Metab. · 1995 · 1257 · 3810.1016/0005-2760(95)00053-F ↗
31. Field · J. Lipid Res. · 1997 · 38 · 34810.1016/S0022-2275(20)37447-2 ↗
32. Brauner · J. Nutr. · 2012 · 142 · 98110.3945/jn.111.157198 ↗
33. Eygeris · Nano Lett. · 2020 · 20 · 454310.1021/acs.nanolett.0c01386 ↗
34. Patel · Nano Lett. · 2017 · 17 · 571110.1021/acs.nanolett.7b02664 ↗
35. Kim · bioRxiv · 202010.1101/2020.07.24.205583 ↗
36. Jayaraman · Angew. Chem., Int. Ed. · 2012 · 51 · 852910.1002/anie.201203263 ↗
37. Sabnis · Mol. Ther. · 2018 · 26 · 150910.1016/j.ymthe.2018.03.010 ↗
38. Hassett · Mol. Ther.–Nucleic Acids · 2019 · 15 · 110.1016/j.omtn.2019.01.013 ↗
39. Dong · Proc. Natl. Acad. Sci. U. S. A. · 2014 · 111 · 395510.1073/pnas.1322937111 ↗
40. Cheng · Nat. Nanotechnol. · 2020 · 15 · 31310.1038/s41565-020-0669-6 ↗
41. Kulkarni · Acc. Chem. Res. · 2019 · 52 · 243510.1021/acs.accounts.9b00368 ↗
42. Paunovska · ACS Nano · 2018 · 12 · 834110.1021/acsnano.8b03640 ↗
43. Payne · Traffic Cph. Den. · 2007 · 8 · 38910.1111/j.1600-0854.2007.00540.x ↗
44. Bänfer · Biomolecules · 2020 · 10 · 123210.3390/biom10091232 ↗
45. Chen · J. Biol. Chem. · 2014 · 289 · 1116210.1074/jbc.M113.531855 ↗
46. Hong · Glycobiology · 2019 · 30 · 49
47. Mansilla Pareja · Front. Cell. Infect. Microbiol. · 2017 · 7 · 11210.3389/fcimb.2017.00112 ↗
48. Jia · Mol. Cell. · 2018 · 70 · 12010.1016/j.molcel.2018.03.009 ↗